烟酰胺在治疗维持性血液透析尿毒症高磷血症患者中的临床应用

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (40 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the effect of nicotinamide in the treatment of hyperphosphatemia in uremia. Methods 20 uremic patients with high phosphorus in maintenance hemodialysis admitted in Xiangya Ping Mine Cooperative Hospital Hemodialysis Center from January 2015 to January 2016 were studied and given oral nicotinamide tablets treatment，after treatment for 3 and 6months，the dataswere statisticed and effectwas evaluated.Results After treatment for3months，serum phosphorusdetection in 35%of patientswith uremia isup to the standard，after treatment for 6months 75%ofwhom.Comparedwithbefore treatment，serum phosphorusand productofcalcium and phosphorus levelweredecreased after treatment for 3 months，and the difference was statistically significant（P＜0.05）；after treatment for 3months，serum calcium and iPTH levels compared with before treatment，the difference was not statistically significant（P＞0.05）.Compared with before treatment，product of calcium and phosphorus and iPTH level after treatment for 6 months were decreased，and the difference was statistically significant（P＜0.05）；after treatment for 6months，serum phosphorus and calcium levels compared with before treatment，the difference was not statistically significant（P＞0.05）.Conclusion Oral nicotinamide tablets can effectively reduce serum phosphorus and product of calcium and phosphorus in patients with maintaining hemodialysis，which does notaffect calcium value and increase the risk of vascular calcification.

Key words： Nicotinamide Hyperphosphatemia Uremia Hemodialysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Dan
	ZHOU Dong-lin
	CHEN Yu

Cite this article:

CHEN Dan,ZHOU Dong-lin,CHEN Yu. Clinicalapplication of nicotinam ide in treatment ofmaintenance hemodialysis patientswith hyperphosphatem ia in urem ia[J]. 中国当代医药, 2016, 23(29): 57-59.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I29/57

［1］	郑慧，刘智楠.碳酸司维拉姆在慢性肾功能不全合并高磷血症患者治疗中的应用［J］.山东医药，2016，56（14）：70-71.
［2］	安小娟，李显文，杨孟雪，等.2型糖尿病酮症酸中毒合并重度急性高磷血症1例报道［J］.现代医药卫生，2016，32 （8）：1276-1277.
［3］	张焱，高峰.血液透析滤过与血液透析联合血液灌流治疗尿毒症顽固性高血压的疗效比较［J］.中国中西医结合急救杂志，2016，23（2）：203-204.
［4］	徐浩.护理指导对肾衰竭血液透析病人高磷血症的干预效果［J］.全科护理，2016，14（11）：1124-1126.
［5］	Shahbazian H，Mohtashami AZ，Ghorbani A，etal.Oral nicotinamide reducesserum phosphorus，increasesHDL，and induces thrombocytopenia in hemodialysis patients：a double-blind randomized clinical trial［J］.Nefrologia，2011，31（1）：58-65.
［6］	Vasantha J，Soundarajan P，Vanitharani N，et al.Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis［J］.Indian JNephrol，2011，21（4）：245-249.
［7］	Liu WS，Chung YT，Yang CY，et al.Serum creatinine determined by jaffe，enzymatic method，and isotope dilution-liquid chromatography-mass spectrometry in patients under hemodialysis［J］.JClin Lab Anal，2012，26（3）：206-214.
［8］	Kong X，Zhang L，Zhang L，et al.Mineral and bone disorder in Chinese dialysis patients：a multicenter study［J］.BMC Nephrol，2012，13（9）：1-7.
［9］	Tripathi V，Bansal S，Alok S，et al.Histopathological changes of radial artery wall in patients of chronic kidney disease stage 5 undergoing AV fistula formation and their correlation with serum iPTH levels［J］.Saudi JKidney Dis Transpl，2015，26（5）：884-889.
［10］	王凤君，张桂月，关美玉.骨化三醇注射液冲击治疗尿毒症继发性甲状旁腺功能亢进的临床疗效观察［J］.中国现代药物应用，2016，10（9）：140-141.
［11］	陈林，刘日光，陈浩雄，等.碳酸镧对维持透析患者高磷血症的疗效分析［J］.现代医院，2014，14（7）：36-37.
［12］	崔文芳，连敏玲.低蛋白饮食治疗维持性血液透析患者高磷血症的临床效果分析［J］.中外医疗，2016，35（2）：33-34.
［13］	佘伟萍，杨伟鹏，刘奕深，等.碳酸镧治疗维持性血液透析患者高磷血症的短期疗效及安全性［J］.吉林医学，2016，37（2）：395-396.
［14］	李荣华.血液透析联合血液灌流对尿毒症高磷血症患者的临床疗效［J］.中国现代药物应用，2014，8（9）：37-38.
［15］	Stamopoulos D，Bakirtzi N，Manios E，et al.Does the extracorporeal circulation worsen anemia in hemodialysis patients？Investigation with advanced microscopes of red blood cells drawn at the beginning and end of dialysis［J］. Int JNanomedicine，2013，8（4）：3887-3894.
［16］	王月芳.还原型谷胱甘肽对尿毒症维持性血液透析患者微炎症干预效果分析［J］.中国医学前沿杂志（电子版），2016，8（3）：101-104.
［17］	廖善霞，杨斌.强化健康教育对慢性肾功能衰竭高磷血症患者的影响［J］.中国现代医生，2014，52（11）：104-107.